
Opinion|Videos|January 10, 2025
The Role of Biomarkers and Biopsy for IPF and PPF
Author(s)Anna Podolanczuk, M.D., M.S.
Anna Podolanczuk, M.D., M.S., discusses how biomarker testing plays a role in diagnosing idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), helping to distinguish these diseases from other respiratory conditions, as well as the role of biopsy and the histopathological features commonly seen in these diseases.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What is the role of biomarker testing in IPF and PPF, and can it be used to distinguish these from other respiratory diseases?
- What is the role of biopsy in identifying patients with IPF and PPF, and what is commonly seen on histopathology?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Langlara, third interchangeable biosimilar to Lantus, approved by FDA
2
FDA approves first treatment for chronic hepatitis D virus
3
Cancer patients taking GLP-1s less likely to develop advanced disease | ASCO 2026
4
Nubeqa edges Xtandi on cognitive side effects | ASCO 2026
5






















